- About bilaterals.org
- How to participate
- Key issues
- Texts of agreements
Ranbaxy deal may help India’s entry into Japan
Financial Express | June 14, 2008
Ranbaxy deal may help India’s entry into Japan
New Delhi, Jun 13 — The Daiichi Sankyo-Ranbaxy Laboratories deal has come as a shot in the arm for India’s Comprehensive Economic Co-operation Agreement (CECA) negotiations with Japan. Indian pharma companies have been unable to break into Japan, the world’s second largest drug market, due to the country’s stringent sanitary and phytosanitary standards, technical barriers to trade (TBT) and environmental norms.
"The acquisition of Ranbaxy is arecognition of the quality of Indian drug and other pharma products bytheir Japanese counterparts. Before signing the CECA (Comprehensive Economic Cooperation Agreement), we will now aggressively push the case of our pharma sector as well as that of the chemicals, bio-tech and cosmetics sectors to ensure that Japan agrees to opening up their market for these products," a government official told FE.
Since the current Japanese standards on drugs and other pharmaceuticals products are higher than the accepted international standards, it amounts to a non-tariff barrier, the officialofficial added. India will ask Japan to bring their national standards to international levels and also ensure that there is a harmonization of SPS and TBT standards of both countries.
The government is, however, seeing the Ranbaxy deal as a bigger opportunity apart from getting a foothold in the $65 billion pharma market. In a bid to pave the way for the entry of Indian health industry into Japan, New Delhi would also pitch for relaxing the norms for movement of doctors, nurse and other health professionals from India to Japan.
Indian industry sees Japan’s drug approval procedures as stricter and time-consuming. Besides, it is also mandatory to get such products are tested in Japan itself as they do not accept products tested outside that country.
India would now demand that if the US FDA (Food and Drug Administration) has given approval to a drug, Japan must also allow it without any further testing. The government is also keeping a close watch on the deal’s impact on the Indian pharma market and if it would result in costlier drugs entering the country.
bilaterals.org and a new ISDS (investor-state dispute settlement) platform to be hosted at bilaterals.org seek to hire a coordinator for their work. This is a great opportunity for someone interested in working on a full-time, paid basis to support people’s struggles against so-called free trade and investment deals globally, through a job share for two separate but complementary projects.
Find out more.
News from the movements
2-Sep-2015 Flush the TPPThe outcome of such a process, based on what we know so far, is what one might reasonably expect: “a wishlist of the 1%–a worldwide corporate power”.
1-Sep-2015 Prensa RuralEl libre comercio se predica como el arreglo óptimo para expandir la producción, reducir los costos de ésta y, como tal, reducir los precios del consumo, lo que en el largo plazo incrementaría la igualdad en el ingreso. Todo esto puede ser cierto. Nunca lo sabremos, puesto que nunca de los nuncas hemos conocido un mundo de libre comercio.
1-Sep-2015 Third World NetworkLess well known than the notorious Trans-Pacific Partnership, the Regional Comprehensive Economic Partnership (RCEP) is engendering growing opposition because of its similar oppressive provisions.
31-Aug-2015 Global Justice NowIn the UK and across Europe, TTIP Free Zones are popping up like people power mushrooms.
28-Aug-2015 ALAIOrganizaciones sindicales, sociales y civiles llaman a crear un frente amplio versus políticas de libre comercio.
27-Aug-2015 Blastingnews.comUna Iniciativa Ciudadana Europea pide apoyos para frenar el TTIP y el CETA.
26-Aug-2015 TNIWhile TTIP is currently the center of attention, our world leaders discuss TiSA, an extensive service agreement meant to put (public) services, like the water supply, in the hands of the international market.
25-Aug-2015 Rojo y Negro
Del 10 al 17 de octubre unámonos a las marchas, manifestaciones masivas y organicemos acciones locales por toda EuropaDel 10 al 17 de octubre unámonos a las marchas, manifestaciones masivas y organicemos acciones locales por toda Europa y América del Norte. ¡No al TTIP, CETA, TPP y TISA!
bilaterals.org is a collaborative space to share information and support movements struggling against bilateral trade and investment deals which serve corporations, not people. Multilingual. Global. No one owns it. Open publishing. Get involved.